A PRECLINICAL EVALUATION OF AMINOPYRIDINES AS PUTATIVE THERAPEUTIC AGENTS IN THE TREATMENT OF BOTULISM

被引：33
作者：
SIMPSON, LL
机构：
[1] THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT PHARMACOL,PHILADELPHIA,PA 19107
[2] THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DIV ENVIRONM MED & TOXICOL,PHILADELPHIA,PA 19107
来源：
INFECTION AND IMMUNITY | 1986年 / 52卷 / 03期
关键词：
D O I：
10.1128/IAI.52.3.858-862.1986
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：858 / 862
页数：5
相关论文
共 50 条
  • [41] Rapid Preclinical Validation of PTGS Therapeutic Agents for Inherited Retinal Degenerations
    Butler, Mark Christian
    Fayazi, Zahra
    Sullivan, Jack M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [42] EVALUATION OF RETINOIDS AS THERAPEUTIC AGENTS IN DERMATOLOGY
    LEWIN, AH
    BOS, ME
    ZUSI, FC
    NAIR, X
    WHITING, G
    BOUQUIN, P
    TETRAULT, G
    CARROLL, FI
    PHARMACEUTICAL RESEARCH, 1994, 11 (02) : 192 - 200
  • [43] EVALUATION OF THE NEWER THERAPEUTIC AGENTS IN OPHTHALMOLOGY
    VORISEK, EA
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1947, 30 (01) : 29 - 40
  • [44] THE EVALUATION OF THERAPEUTIC AGENTS - WOLF,S
    OZARIN, LD
    MENTAL HOSPITALS, 1957, 8 (01): : 22 - 22
  • [45] Design and preclinical evaluation of single agents with antitubulin and antiangiogenic activity as antitumor agents
    Gangjee, Aleem
    Pavana, Roheeth Kumar
    Zhang, Xin
    Ihnat, Michael
    Hamel, Ernest
    CANCER RESEARCH, 2012, 72
  • [46] Validation of preclinical models of melanoma: tools for therapeutic evaluation
    Mourah, S.
    Varna, M.
    Sadoux, A.
    Yahiaoui, S.
    Podgorniak, M. P.
    Leclert, G.
    Pages, C.
    May, P.
    Marika, P.
    Soulier, J.
    Feugeas, J. P.
    Janin, A.
    Lebbe, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 39 - 39
  • [47] Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma
    Hanes, Robert
    Grad, Iwona
    Lorenz, Susanne
    Stratford, Eva W.
    Munthe, Else
    Reddy, Chilamakuri Chandra Sekhar
    Meza-Zepeda, Leonardo A.
    Myklebost, Ola
    ONCOTARGET, 2016, 7 (34) : 54583 - 54595
  • [48] ENZYMATIC EVALUATION OF THERAPEUTIC AGENTS IN CANCER
    WEST, PM
    RAPAPORT, SI
    TEMPEREAU, CE
    CANCER, 1951, 4 (01) : 177 - 183
  • [49] Mercury exposure: Evaluation and intervention - The inappropriate use of chelating agents in the diagnosis and treatment of putative mercury poisoning
    Risher, JF
    Amler, SN
    NEUROTOXICOLOGY, 2005, 26 (04) : 691 - 699
  • [50] Preclinical prospects of investigational agents for hearing loss treatment
    Le Prell, Colleen G.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (08) : 685 - 692
12345